Connect with us
[bsa_pro_ad_space id=12]

COVID-19

So. Who gets the ventilators?

Published

7 minute read

This is posted with permission from the author, Neil MacDonald.  It is originally posted at neilmacdonald.me

So. Who gets the ventilators?

I wish Sophie Gregoire Trudeau good health, and a complete recovery in her quarantine. The same for the lovely Margaret Trudeau, if she comes down with COVID-19. Both women were at the same speaking engagement in London; presumably, that is where Madame Gregoire Trudeau contracted the virus.

If, heaven forfend, either woman develops the sort of severe respiratory difficulties that have killed other COVID-19 patients, I hope they will both have access to peerless medical care, and a ventilator. Actually, I am certain they will.

One is the prime minister’s wife, the other his mother. Privilege has its privileges.

At the same time – and here comes the kicker – I am not at all certain that, if I or any of my aged relatives come down with the disease in the uncertain and increasingly terrifying weeks to come, there will be ventilators for us. And as one American epidemiologist put it recently, the alternative to ventilation for someone with extreme respiratory symptoms is death. As a despairing Italian physician put it on social media from the horrors of his triage centre in Bergamo: “Every ventilator becomes like gold.”

Here is the math: Health Minister Patty Hajdu says between 30 and 70 per cent of Canadians will likely be infected. The mortality rate of COVID-19 is between two and three per cent. Assuming the optimistic end of Hajdu’s estimate, and the optimistic end of the mortality rate, we are still talking about 225,000 people dying, and, as the despairing Italian physician says, the diagnosis is always the same: Bilateral interstitial pneumonia. Meaning those patients’ lungs are so badly compromised the only thing that has a chance of saving them is a ventilator, or mechanical breathing apparatus. It alone can infuse the lungs with enough oxygen to maintain life.

Now: We are told Canada has about 5,000 ventilators. That’s one ventilator for every 45 of those dying patients. Unless Canada somehow acquires a lot more of the machines, and the entire world is now chasing them, there will be rationing. That is what has been happening in Italy. Doctors there have been given the ghastly job of deciding who receives ventilation, and who is sent home to meet their fate.

Now, let’s add something else to the equation: In Canada, the law prevents citizens from paying for core medical care, which a ventilator surely is. In principle, ventilators will be rationed, well, rationally.

But that’s not how the system really works.

In Canada, influence and power get you to the front of the line. Does anyone really believe that cabinet ministers or premiers or captains of industry or very senior government officials sit in waiting rooms, or have a hard time finding a family doctor? Or that those of us with professional or family connections aren’t treated as privileged entities?

So the big question – the crucial, life-or-death question as this virus tears through the population – will very quickly be this: who gets the ventilators?

No doubt, an attempt will be made to lay down a set of objective criteria. They probably already exist. It makes sense to ventilate patients who stand the best chance of surviving. A physician friend in Italy unilaterally decided to send very old people home, along with anyone whose health was already severely compromised by previous morbidities.

But imagine the pressure on a Canadian doctor, or hospital dependent on government funding, when the aged relative of a very powerful politician needs ventilation. Or a very rich person who has donated generously to the hospital. Or the mother or father of a person whose role in the economy is considered so crucial that he or she must not be distracted by familial worries.

Jane Philpott, Justin Trudeau’s first health minister, once declared that not being able to buy your way to the front of the line is a “core Canadian value.” The remark was rather gormless, I thought at the time, given the reality of the system. Doctor friends of mine thought it was hysterical.
But the big test is coming. The public deserves to know precisely how lifesaving care will be allocated. The public has a right to transparent fairness.

My guess: fairness and objective allocation of resources will slam into the wall of privilege. We shall see. We shall also see how intrepid the media is on this subject. So far, it hasn’t been.

From neilmacdonald.me

Neil Macdonald spent 43 years reporting on politics, wars, elections, revolutions, booms, crashes, coups, and the struggles of ordinary human beings in the unforgiving, bewildering rush of history.

He worked as an editor and reporter in three newspapers before moving to CBC News, for which he covered Quebec before moving to Parliament Hill, then abroad as a foreign correspondent in the Middle East and Washington, DC., and finally as the CBC’s opinion columnist.

He has stood in Iraq watching missiles strike, in Bethlehem watching people welcome the new millennium, in Jerusalem watching an intifada erupt, and in Chicago watching Barack Obama accept the American presidency. He followed the Pope through the Holy Land, tracked down Hitler’s last general in Europe, covered the triumphant arrival and subsequent humiliation of Jean-Bertrand Aristide in Haiti, revealed the plotters who killed Rafiq Hariri in Beirut, and documented the financial horrors unleashed on America’s cities by Wall Street.

He speaks French, having grown up in Quebec, reasonably good English, and sufficient Arabic. He lives in Ottawa.

Learning at home? Here’s a list of links to take you on a “Virtual Field Trip”

After 15 years as a TV reporter with Global and CBC and as news director of RDTV in Red Deer, Duane set out on his own 2008 as a visual storyteller. During this period, he became fascinated with a burgeoning online world and how it could better serve local communities. This fascination led to Todayville, launched in 2016.

Follow Author

COVID-19

Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

Published on

From LifeSiteNews

By Nicolas Hulscher, MPH

A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna

A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.

The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:

Study Overview

  • Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
  • Intervention: Two doses of either:
    • BNT162b2 (Pfizer-BioNTech)
    • mRNA-1273 (Moderna)
  • Follow-up Duration: 12 months after second dose.
  • Comparison: Head-to-head between Pfizer vs. Moderna recipients.
  • Main Outcomes:
    • All-cause mortality
    • Cardiovascular mortality
    • COVID-19 mortality
    • Non-COVID-19 mortality

All-cause mortality

Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.

  • Pfizer Risk: 847.2 deaths per 100,000 people
  • Moderna Risk: 617.9 deaths per 100,000 people
  • Risk Difference:
    ➔ +229.2 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.37 (i.e., 37% higher mortality risk with Pfizer)
  • Odds Ratio (Adjusted):
    ➔ 1.384 (95% CI: 1.331–1.439)

Cardiovascular mortality

Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.

  • Pfizer Risk: 248.7 deaths per 100,000 people
  • Moderna Risk: 162.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +86.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.53 (i.e., 53% higher cardiovascular mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.540 (95% CI: 1.431–1.657)

COVID-19 mortality

Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.

  • Pfizer Risk: 55.5 deaths per 100,000 people
  • Moderna Risk: 29.5 deaths per 100,000 people
  • Risk Difference:
    ➔ +26.0 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.88 (i.e., 88% higher COVID-19 mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.882 (95% CI: 1.596–2.220)

Non-COVID-19 mortality

Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.

  • Pfizer Risk: 791.6 deaths per 100,000 people
  • Moderna Risk: 588.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +203.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.35 (i.e., 35% higher non-COVID mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.356 (95% CI: 1.303–1.412)

Biological explanations

The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:

The paper hypothesizes differences between Pfizer and Moderna may be due to:

  • Different lipid nanoparticle compositions
  • Differences in manufacturing, biodistribution, or storage conditions

Final conclusion

Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.

Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.

As the authors conclude:

These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.

Reprinted with permission from Focal Points.

Continue Reading

COVID-19

Canada’s health department warns COVID vaccine injury payouts to exceed $75 million budget

Published on

Fr0m LifeSiteNews

By Clare Marie Merkowsky

A Department of Health memo warns that Canada’s Vaccine Injury Support Program will exceed its $75 million budget due to high demand, with $16 million already paid out.

COVID vaccine injury payments are expected to go over budget, according to a Canadian Department of Health memo.

According to information published April 28 by Blacklock’s Reporter, the Department of Health will exceed their projected payouts for COVID vaccine injuries, despite already spending $16 million on compensating those harmed by the once-mandated experimental shots.

“A total $75 million in funding has been earmarked for the first five years of the program and $9 million on an ongoing basis,” the December memo read. “However the overall cost of the program is dependent on the volume of claims and compensation awarded over time, and that the demand remains at very high levels.”

“The purpose of this funding is to ensure people in Canada who experience a serious and permanent injury as a result of receiving a Health Canada authorized vaccine administered in Canada on or after December 8, 2020 have access to a fair and timely financial support mechanism,” it continued.

Canada’s Vaccine Injury Support Program (VISP) was launched in December 2020 after the Canadian government gave vaccine makers a shield from liability regarding COVID-19 jab-related injuries.

While Parliament originally budgeted $75 million, thousands of Canadians have filed claims after received the so-called “safe and effective” COVID shots. Of the 3,060 claims received to date, only 219 had been approved so far, with payouts totaling over $16 million.

Since the start of the COVID crisis, official data shows that the virus has been listed as the cause of death for less than 20 kids in Canada under age 15. This is out of six million children in the age group.

The COVID jabs approved in Canada have also been associated with severe side effects such as blood clots, rashes, miscarriages, and even heart attacks in young, healthy men.

Additionally, a recent study done by researchers with Canada-based Correlation Research in the Public Interest showed that 17 countries have found a “definite causal link” between peaks in all-cause mortality and the fast rollouts of the COVID shots as well as boosters.

Interestingly, while the Department of Health has spent $16 million on injury payouts, the Liberal government spent $54 million COVID propaganda promoting the vaccine to young Canadians.

The Public Health Agency of Canada especially targeted young Canadians ages 18-24 because they “may play down the seriousness of the situation.”

The campaign took place despite the fact that the Liberal government knew about COVID vaccine injuries, according to a secret memo.

Continue Reading

Trending

X